Please assess the completion status of the following clinical trial:

Trial Title: A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Among other criteria, patients must meet all of the following conditions to be eligible to be in the study:~1. 18 years of age or older.~2. Have a cancer type that is known to express NY-ESO-1, including (but not limited to) cancer of the bladder, breast, ovary, non-small cell lung cancer, myeloma, sarcoma or melanoma.~3. Have cancer that has progressed after any therapies with curative potential or approved salvage therapies (if such therapies exist).~4. Have evaluable or measurable tumors.~5. Have adequate blood, bone marrow, liver and kidney function as determined by laboratory tests.~6. Have a sample of tumor tissue available for NY-ESO-1 testing at a central laboratory.~7. If of childbearing potential (male or female), agree to practice an effective form of contraception during study treatment.~Exclusion Criteria:~Among other criteria, patients who meet any of the following conditions are NOT eligible to be in the study:~1. Are receiving treatment with immunosuppressive or immunomodulatory agents, including any systemic steroid (inhaled or topically applied steroids are permitted).~2. Has a known infection with HIV, HBV or HCV, or any other active infection requiring systemic antibiotic treatment.~3. Has active central nervous system tumors.~4. Any underlying medical condition that in the Principal Investigator's opinion will make the administration of study drug hazardous or otherwise interfere with the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).